Lysine deacetylase inhibitors have low selectivity in cells and exhibit predominantly off‐target effects
Lysine deacetylases (KDACs or HDACs) are metal‐dependent enzymes that regulate lysine acetylation, a post‐translational modification that is present on thousands of human proteins, essential for many cellular processes, and often misregulated in diseases. The selective inhibition of KDACs would allo...
Saved in:
| Main Authors: | Kiara E. Bornes, Marcus A. Moody, Thomas M. Huckaba, Megan C. Benz, Emily C. McConnell, Maryam Foroozesh, Van H. Barnes, Bridgette M. Collins‐Burow, Matthew E. Burow, Terry J. Watt, Tasha B. Toro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | FEBS Open Bio |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/2211-5463.13896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
by: Antonio Curcio, et al.
Published: (2024-05-01) -
HDACs and Their Inhibitors on Post-Translational Modifications: The Regulation of Cardiovascular Disease
by: Siyi Yang, et al.
Published: (2025-07-01) -
Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents
by: Jason H. Gill, et al.
Published: (2025-12-01) -
Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases
by: Maria A. Theodoropoulou, et al.
Published: (2024-12-01) -
Ferrocene Derivatives as Histone Deacetylase Inhibitors: Synthesis and Biological Evaluation
by: Rostislava Angelova, et al.
Published: (2025-01-01)